Journals / Diagnostic and Interventional Radiology / 2019 / Cilt: 25 - Sayı: 6

Assessment of the compliance with minimum acceptable technical parameters proposed by PI-RADS v2 guidelines in multiparametric prostate MRI acquisition in tertiary referral hospitals in the Republic of Turkey

Pages
421–427
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Awareness to the minimum acceptable technical parameters ofmpMRI should be increased to potentially improve the quality of prostate cancer imaging.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSEAlthough the clinical use of multiparametric prostate magnetic resonance imaging (mpMRI) isincreasing, the adherence to parameters for mpMRI, which had been described in the ProstateImaging-Reporting and Data System version 2 (PI-RADS v2) for an optimum image acquisition isunknown.
📊
Key Findings & Data:In this paper, we aimed to determine the compliance with the minimum acceptabletechnical parameters for prostate mpMRI defined by PI-RADS v2 in tertiary care centers in Turkey.METHODSWe sent a survey to all radiology departments of tertiary referral hospitals in Turkey (n=120)to evaluate their adherence to PI-RADS v2 technical specifications.
💡
Conclusion & Impact:Awareness to the minimum acceptable technical parameters ofmpMRI should be increased to potentially improve the quality of prostate cancer imaging.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

PURPOSEAlthough the clinical use of multiparametric prostate magnetic resonance imaging (mpMRI) isincreasing, the adherence to parameters for mpMRI, which had been described in the ProstateImaging-Reporting and Data System version 2 (PI-RADS v2) for an optimum image acquisition isunknown. In this paper, we aimed to determine the compliance with the minimum acceptabletechnical parameters for prostate mpMRI defined by PI-RADS v2 in tertiary care centers in Turkey.METHODSWe sent a survey to all radiology departments of tertiary referral hospitals in Turkey (n=120)to evaluate their adherence to PI-RADS v2 technical specifications. Statistical analysis was performed using chi-square, Fisher exact, ANOVA, and the Student t tests. The cutoff values for image acquisition times were also determined with receiver operating characteristics (ROC) analysis. P values <0.05 were considered statistically significant.RESULTSOne hundred and eleven clinics responded to our survey (response rate, 92.5%). Prostate MRIwas reported to be performed in 61 centers, of which 26 (42.6%) used 3 T (Tesla) scanner while35 (57.4%) used 1.5 T. The adherence to slice thickness, in-plane phase and frequency resolutionson T2-weighted imaging were 68.9%, 41%, and 9.8%, respectively. The adherence to the sameparameters on diffusion-weighted imaging (DWI) were higher compared with T2-weighted imaging (85.2%, 62.3%, and 78.7%, respectively). In comparative analysis, the adherence to slicethickness, field of view (FOV) and in-plane phase resolution on T2-weighted imaging were higherfor 3 T compared with 1.5 T scanners (P = 0.004, P = 0.041, and P = 0.001, respectively). T2-weighted imaging acquisition time was significantly longer for the centers that adhered to FOV (P =0.034) and in-plane T2-weighted imaging phase resolution (P = 0.028). The DWI scan time wassignificantly longer when they adhered to DWI-FOV (P = 0.014) and b value ≥1400 s/mm2 (P =0.008). The calculated cutoff of scan times were 220 s in T2-weighted imaging and 312 s in DWIto ensure the compliance with voxel sizes and b value criteria.CONCLUSIONThe tertiary referral centers in Turkey did not meet majority of the technical specifications of PI-RADSv2 during prostate MRI acquisition. Awareness to the minimum acceptable technical parameters ofmpMRI should be increased to potentially improve the quality of prostate cancer imaging.

🔖

Cite This Article

COŞKUN, M., SARP, A. F., KARASU, Ş., GELAL, M. F., TÜRKBEY, B. (2019). Assessment of the compliance with minimum acceptable technical parameters proposed by PI-RADS v2 guidelines in multiparametric prostate MRI acquisition in tertiary referral hospitals in the Republic of Turkey. Diagnostic and Interventional Radiology, Cilt: 25 - Sayı: 6, 421–427. https://ajindex.com/articles/349998

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Jelle O. Barentsz JO, Richenberg J, et al. ESUR prostate MR guidelines. Eur Radiol 2012
  2. 746–757. [CrossRef] 2. PI-RADS Prostate Imaging Reporting and Data System Version 2 (2015) American College of Radiology. 3. Rosenkrantz AB, Hemingway J, Hughes DR, Duszak R Jr, Allen B Jr, Weinreb JC. Evolving use of prebiopsy prostate magnetic resonance imaging in the medicare population. J Urol 2018
  3. 89–94. [CrossRef] 4. VanderWeele DJ, Turkbey B, Sowalsky AG. Precısıon management of localized prostate cancer. Expert Rev Precis Med Drug Dev 2016
  4. 505–515. [CrossRef] 5. Rosenkrantz AB, Verma S, Choyke P, et al. Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR. J Urol 2016
  5. 1613–1618. [CrossRef] 6. Gupta RT, Spilseth B, Froemming AT. How and why a generation of radiologists must be trained to accurately interpret prostate mpMRI. Abdom Radiol (NY) 2016
  6. 803–804. [CrossRef] 7. Esses SJ, Taneja SS, Rosenkrantz AB. Imaging facilities' adherence to PI-RADS v2 minimum technical standards for the performance of prostate MRI. Acad Radiol 2018
  7. 188–195. [CrossRef] 8. https://data.oecd.org/healthcare/magnetic-resonance-imaging-mri-exams.htm [CrossRef] 9. Acar O, Esen T, Çolakoğlu B, et al. Multiparametric MRI guidance in first-time prostate biopsies: what is the real benefit? Diagn Interv Radiol 2015
  8. 271–276. [CrossRef] 10. Tavukçu HH, Aytaç Ö, Balcı NC, Kulaksızoğlu H, Atuğ F. The efficacy and utilisation of preoperative multiparametric magnetic resonance imaging in robot-assisted radical prostatectomy: does it change the surgical dissection plan? Turk J Urol 2017
  9. 470–475. [CrossRef] 11. Okcelik S, Soydan H, Ates F, et al. Evaluation of PCA3 and multiparametric MRI's: collective benefits before deciding initial prostate biopsy for patients with PSA level between 3-10ng/mL. Int Braz J Urol 2016
  10. 449–455. [CrossRef] 12. http://www.turkstat.gov.tr/Start.do 13. Othman AE, Falkner F, Weiss J, et al. Effect of temporal resolution on diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging of the prostate. Invest Radiol 2016
  11. 290–296. [CrossRef] 14. Ream JM, Doshi AM, Dunst D, et al. Dynamic contrast-enhanced MRI of the prostate: an intraindividual assessment of the effect of temporal resolution on qualitative detection and quantitative analysis of histopathologically proven prostate cancer. J Magn Reson Imaging 201